Collaboration between stakeholders and the federal government is critical to addressing underlying gaps in patient care, said Debbie Witchey, MHA, executive vice president of the Healthcare Leadership Council.
Collaboration between stakeholders and the federal government is critical to addressing underlying gaps in patient care, said Debbie Witchey, MHA, executive vice president of the Healthcare Leadership Council.
Transcript
Through your experience assisting in the creation of public-private partnerships, how vital is it for stakeholders and providers to collaborate to avoid underlying gaps in patient care?
Collaboration from my perspective is critically important, both between stakeholders, among stakeholders, but also with including the federal government in that. We’ve done a lot of work on disaster preparedness and what we’ve seen happen is the government has 1 silo where they’re working in, and then the other stakeholders are either working with them in their own sectors or sometimes they’re crossing over; but you’re trying to get medical records in a community when they’re not available, or trying to get medicines or medical supplies to people. We literally were having CEOs of healthcare entities calling their personal friends to try to get airplanes and trying to get things into people. So, what we’ve seen, particularly since Puerto Rico, is that the federal government has realized that they need to interact better and have more interaction with stakeholders in the private sector. So, we’re starting to work together—the National Academy of Medicine is working together and you’re already seeing, although we certainly haven’t had the severity of situation that we had last year, but seeing things work better–so, that’s 1 example.
Another example where I think stakeholders working together is critically important is in the opioid space. So, you can’t just address the opioid issue from a law enforcement perspective or from a healthcare perspective, but everyone really needs to come together and try to address the issue. When that started to happen through a lot of efforts both legislative and on the private sector side in the healthcare community and non-healthcare community, we’re slowly starting to see the death rate go down.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More